GARDNER PHYLLIS
Insider CIK 1238646 · MDXG Director · RVNC Director · CWBR Director · CORI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MDXG MIMEDX GROUP, INC. | A Award | 2023-06-13 | 2023-06-15 | 35,354 | $4.95 | $175.0K | 117,024 | SEC↗ |
| MDXG MIMEDX GROUP, INC. | A Award | 2022-06-07 | 2022-06-13 | 44,191 | $3.96 | $175.0K | 81,670 | SEC↗ |
| MDXG MIMEDX GROUP, INC. | A Award | 2021-05-27 | 2021-05-28 | 17,056 | $10.26 | $175.0K | 37,479 | SEC↗ |
| MDXG MIMEDX GROUP, INC. | A Award | 2021-04-28 | 2021-04-29 | 4,084 | $10.71 | $43.7K | 20,423 | SEC↗ |
| MDXG MIMEDX GROUP, INC. | A Award | 2021-04-28 | 2021-04-29 | 16,339 | $10.71 | $175.0K | 16,339 | SEC↗ |
| CWBR CohBar, Inc. | A Award deriv | 2021-04-26 | 2021-04-28 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-05-14 | 2020-05-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-05-14 | 2020-05-15 | 6,000 | — | $0 | 16,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2019-05-09 | 2019-05-10 | 4,500 | — | $0 | 10,500 | SEC↗ |
| CWBR CohBar, Inc. | A Award deriv | 2019-02-08 | 2019-02-12 | 200,000 | — | $0 | 200,000 | SEC↗ |
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-28 | 12,000 | $12.50 | $150.0K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-28 | 15,000 | $12.50 | $187.5K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-28 | 15,000 | $12.50 | $187.5K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-28 | 12,000 | $12.50 | $150.0K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer deriv | 2018-11-27 | 2018-11-28 | 7,920 | $12.50 | $99.0K | 0 | SEC↗ |
| CORI Corium International, Inc. | D To issuer | 2018-11-27 | 2018-11-28 | 34,203 | $12.50 | $427.5K | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2018-05-10 | 2018-05-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2018-05-10 | 2018-05-11 | 3,000 | — | $0 | 6,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2018-03-16 | 2018-03-16 | 4,000 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise deriv | 2018-03-16 | 2018-03-16 | 1,333 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | S Sale | 2018-03-16 | 2018-03-16 | 5,333 | $31.51 | $168.0K | 3,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2018-03-16 | 2018-03-16 | 4,000 | $2.55 | $10.2K | 7,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | M Exercise | 2018-03-16 | 2018-03-16 | 1,333 | $2.55 | $3.4K | 8,333 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2017-12-01 | 2017-12-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CORI Corium International, Inc. | M Exercise deriv | 2017-08-21 | 2017-08-21 | 33,064 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | M Exercise | 2017-08-21 | 2017-08-21 | 33,064 | $2.12 | $70.1K | 34,203 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2017-05-11 | 2017-05-12 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2017-05-11 | 2017-05-12 | 3,000 | — | $0 | 3,000 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2016-12-22 | 2016-12-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2016-05-05 | 2016-05-09 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-05-07 | 2015-05-14 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CORI Corium International, Inc. | M Exercise deriv | 2015-03-27 | 2015-03-30 | 1,139 | — | $0 | 0 | SEC↗ |
| CORI Corium International, Inc. | M Exercise | 2015-03-27 | 2015-03-30 | 1,139 | $0.20 | $228 | 1,139 | SEC↗ |
| CORI Corium International, Inc. | A Award deriv | 2014-12-04 | 2014-12-05 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2014-04-08 | 2014-04-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 41,312 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 47,252 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 115,787 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 115,337 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 124,558 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise deriv | 2014-02-11 | 2014-02-11 | 12,839 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise | 2014-02-11 | 2014-02-11 | 12,839 | — | $0 | 457,085 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 41,312 | — | $0 | 444,246 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 402,934 | — | $0 | 402,934 | SEC↗ |